| B02BD02 |
Coagulation factor VIII (Octocog alfa) |
KOGENATE BAYER |
Powder and solvent for solution for injection |
powder: 500 IU; solvent: 2.5 ml (200 IU/ml) |
|
1 vial + 1 pre-filled syringe + 1 syringe plunger rod + 1 vial adapter +1 venipuncture set + 4 swabs + 2 plasters |
Bayer Pharma AG, Германия |
500 |
IU |
691.9 |
613.53998 |
613.54 |
100% |
|
Съгласно РУ |
№ 20/15,07,2009 г.; КЦРР-259/06.03.2012; КЦРР-2952/20.03.2013 г.; НСР-3235/14.04.2014; НСР-3267/14.04.2014; НСР-9627/23.06.2016 |
42584 |
08.09.2012 |
Активен |
2758 |
| B02BD02 |
Coagulation factor VIII (Octocog alfa) |
KOGENATE BAYER |
Powder and solvent for solution for injection |
powder: 500 IU; solvent: 2.5 ml (200 IU/ml) |
|
1 vial + 1 Bio-Set device + 1 pre-filled syringe + 1 syringe plunger rod + 1 venipuncture set + 4 swabs + 2 plasters |
Bayer Pharma AG, Германия |
500 |
IU |
691.9 |
613.53998 |
613.54 |
100% |
|
Съгласно РУ |
КЦРР-2951/20.03.2013 г.; НСР-3235/14.04.2014; НСР-3267/14.04.2014; НСР-9628/23.06.2016 |
42584 |
08.09.2012 |
Активен |
2757 |
| B02BD02 |
Coagulation factor VIII (Octocog alfa) |
KOGENATE BAYER |
Powder and solvent for solution for injection |
250 |
IU |
1 |
Bayer Pharma AG, Германия |
500 |
IU |
356.06 |
674.82501 |
337.41 |
100% |
|
Съгласно РУ |
КЦРР-1871/15.12.2012 г; НСР-1277/25.09.2013; НСР-3803/16.06.2014. |
16.07.2014 |
|
Заличен |
2147 |
| B02BD02 |
Coagulation Factor VIII (Turoctocog Alfa) |
NovoEight |
Powder and solvent for solution for injection |
500 |
IU |
1 vial + 1 pre- filled syringe + 1 vial adapter |
Novo Nordisk A/S, Дания |
500 |
IU |
740.36 |
613.53998 |
613.54 |
100% |
|
Съгласно РУ |
; НСР-9206/05.05.2016 |
02.06.2016 |
|
Активен |
4038 |
| B02BD02 |
Coagulation Factor VIII (Simoctocog Alfa) |
Nuwiq |
Powder and solvent for solution for injection |
500 |
IU |
1 vial (powder) + 1 pre-filled syringe (solvent) + 1 vial adapter |
Octapharma AB, Elersvägen 40, 112 75 Stockholm, Швеция, Швеция |
500 |
IU |
740.36 |
613.53998 |
613.54 |
100% |
|
Съгласно РУ |
НСР-7214/09.10.2015 |
02.01.2016 |
|
Активен |
4082 |
| B02BD02 |
Coagulation factor VIII (Octocog alfa) |
Recombinate 1000 IU |
Powder and solvent for solution for injection |
1000 |
IU |
1 |
Baxter AG, Австрия |
500 |
IU |
1278.13 |
639.065 |
1278.13 |
100% |
|
Съгласно РУ |
№ 190/ 22.08.2011; КЦРР-259/06.03.2012; КЦРР-1549/01.11.2012 |
04.01.2013 |
08.09.2012 |
Заличен |
1147 |
| B02BD02 |
Coagulation factor VIII (Octocog alfa) |
Recombinate 250 IU |
Powder and solvent for solution for injection |
250 |
IU |
1 |
Baxter AG, Австрия |
500 |
IU |
328.36 |
645.08002 |
322.54 |
100% |
|
Съгласно РУ |
№ 190/ 22.08.2011; КЦРР-259/06.03.2012; КЦРР-2102/25.01.2013. |
20.02.2013 |
08.09.2012 |
Заличен |
1145 |
| B02BD02 |
Coagulation factor VIII (Octocog alfa) |
Recombinate 500 IU |
Powder and solvent for solution for injection |
500 |
IU |
1 |
Baxter AG, Австрия |
500 |
IU |
645.08 |
645.08002 |
645.08 |
100% |
|
Съгласно РУ |
№ 190/ 22.08.2011; КЦРР-259/06.03.2012; КЦРР-2102/25.01.2013. |
20.02.2013 |
08.09.2012 |
Заличен |
1146 |
| B02BD02 |
Coagulation factor VIII (Moroctocog alfa) |
ReFacto AF |
Powder and solvent for solution for injection |
500 IU |
|
1 pre filled syringe + 1 plunger rod + 1 sterile infusion set + 2 alcohol swabs + 1 plaster + 1 gauze + 1 vented sterile cap |
Pfizer Limited, Обединено Кралство |
500 |
IU |
613.54 |
613.53998 |
613.54 |
100% |
|
Съгласно РУ |
НСР-5767/09.03.2015.; НСР-7531/19.11.2015. |
02.01.2016 |
|
Активен |
3640 |
| B02BD02 |
Coagulation factor VIII (Moroctocog alfa) |
ReFacto AF |
Powder and solvent for solution for injection |
1000 |
IU |
1 |
Pfizer Limited, Обединено Кралство |
500 |
IU |
1340.68 |
670.34003 |
1340.68 |
100% |
|
Съгласно РУ |
№ 180/ 27.07.2011.; КЦРР-1462/02.10.2012.; КЦРР-2039/21.01.2013; КЦРР-2536/14.03.2013. |
04.04.2013 |
08.09.2012 |
Заличен |
1648 |
| B02BD02 |
Coagulation factor VIII (Moroctocog alfa) |
ReFacto AF |
Powder and solvent for solution for injection |
500 |
IU |
1 |
Pfizer Limited, Обединено Кралство |
500 |
IU |
636.13 |
613.53998 |
613.54 |
100% |
|
Съгласно РУ |
№ 180/ 27.07.2011.; КЦРР-1462/02.10.2012; НСР-2501/24.01.2014.; НСР-7012/25.08.2015. |
02.01.2016 |
08.09.2012 |
Активен |
2453 |
| B02BD02 |
Coagulation factor VIII (Moroctocog alfa) |
ReFacto AF |
Powder and solvent for solution for injection |
250 |
IU |
1 |
Pfizer Limited, Обединено Кралство |
500 |
IU |
348.11 |
674.82501 |
337.41 |
100% |
|
Съгласно РУ |
№ 180/ 27.07.2011.; КЦРР-1462/02.10.2012; НСР-3155/26.03.2014 |
16.04.2014 |
08.09.2012 |
Заличен |
1013 |
| B02BD03 |
coagulation factor, Factor VIII inhibitor bypassing activity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| B02BD03 |
factor VIII inhibitor bypassyng activity |
Feiba NF |
Powder and solvent for solution for injection |
500 U |
|
1 pre-filled syringe + powd.vial + solv.vial 20 ml + adm.set |
Baxter AG, Австрия |
10000 |
IU |
770.88 |
15417.59961 |
770.88 |
100% |
|
Съгласно РУ |
№ 190/ 22.08.2011; НСР-2195/20.12.2013 |
16.02.2014 |
08.09.2012 |
Активен |
2439 |
| B02BD04 |
Coagulation factor IX |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| B02BD04 |
Coagulation factor IX |
Aimafix DI |
Powder and solvent for solution for infusion |
500 |
IU |
1 |
Kedrion S.p.A., Италия |
350 |
IU |
316.18 |
221.1049 |
316.18 |
100% |
|
Съгласно РУ |
№ 164/ 20.04.2011 |
|
08.09.2012 |
Активен |
369 |
| B02BD04 |
Coagulation factor IX |
IMMUNINE |
Powder and solvent for solution for injection/infusion |
600 |
IU |
1 |
Бакстер България ЕООД, България |
350 |
IU |
486.84 |
221.1049 |
378.09 |
100% |
|
Съгласно РУ |
№ 190/ 22.08.2011; НСР-2198/20.12.2013; НСР-3381/29.04.2014 |
02.06.2014 |
08.09.2012 |
Активен |
2442 |
| B02BD04 |
Coagulation factor IX |
OCTANINE F 1000 |
Powder and solvent for solution for injection |
1000 |
IU |
1 |
Octapharma (IP) Ltd., Обединено Кралство |
350 |
IU |
799.54 |
221.1049 |
632.36 |
100% |
|
Съгласно РУ |
№ 162/ 20.04.2011; НСР-7583/26.11.2015. и КП-10/28.01.2016. |
02.03.2016 |
08.09.2012 |
Активен |
766 |
| B02BD04 |
Coagulation factor IX |
OCTANINE F 500 |
Powder and solvent for solution for injection |
500 |
IU |
1 |
Octapharma (IP) Ltd., Обединено Кралство |
350 |
IU |
405.78 |
221.1049 |
316.18 |
100% |
|
Съгласно РУ |
№ 162/ 20.04.2011; КП-26/15.02.2016 и НСР-7510/19.11.2015 |
02.04.2016 |
08.09.2012 |
Активен |
765 |
| B02BD06 |
Coagulation factor VIII, Factor von Willebrand |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| B02BD06 |
Coagulation factor VIII, Factor von Willebrand |
Wilate 1000 |
Powder and solvent for solution for injection |
1000 |
IU |
1 |
Octapharma (IP) Ltd., Обединено Кралство |
7200 |
IU |
938.96 |
6760.51221 |
938.96 |
100% |
|
Съгласно РУ |
НСР-1794/25.11.2013; НСР-5155/27.11.2014; НСР-6059/16.04.2015. |
16.05.2015 |
|
Заличен |
3419 |
| B02BD06 |
Coagulation factor VIII, Factor von Willebrand |
WILATE 450 powder for solution for injection 450 IU x 1 |
Powder and solvent for solution for injection |
450 |
IU |
1 |
Octapharma (IP) Ltd., Обединено Кралство |
7200 |
IU |
962.53 |
6845.75977 |
427.86 |
100% |
|
Съгласно РУ |
№ 162/ 20.04.2011; НСР-3931/30.06.2014 |
02.08.2014 |
08.09.2012 |
Заличен |
723 |
| B02BD06 |
Coagulation factor VIII, Factor von Willebrand |
Wilate 500 |
Powder and solvent for solution for injection |
500 |
IU |
1 |
Octapharma (IP) Ltd., Обединено Кралство |
7200 |
IU |
472.57 |
6751 |
472.57 |
100% |
|
Съгласно РУ |
НСР-1794/25.11.2013; НСР-5154/27.11.2014; КП-394/06.11.2015 и НСР-7055/03.09.2015 |
02.12.2015 |
|
Активен |
3418 |
| B02BD06 |
Coagulation factor VIII, Factor von Willebrand |
WILATE 900 powder for solution for injection 900 IU x 1 |
Powder and solvent for solution for injection |
900 |
IU |
1 |
Octapharma (IP) Ltd., Обединено Кралство |
7200 |
IU |
856.92 |
6845.75977 |
855.72 |
100% |
|
Съгласно РУ |
№ 162/ 20.04.2011; КЦРР-2256/11.02.2013 и КП-4/05.02.2014; НСР-3931/30.06.2014 |
02.08.2014 |
08.09.2012 |
Заличен |
2556 |
| B02BD08 |
Eptacog alfa (activated) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|